These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4820014)

  • 1. Proceedings: 1-Desamino-8-D-arginine vasopressin and fibrinolysis in man.
    Gader AM; Da Costa J; Cash JD
    Scott Med J; 1974 Jan; 19(1):56-7. PubMed ID: 4820014
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, I-desamino-8-d-arginine vasopressin, angiotensin and oxytocin in man.
    Cash JD; Gader AM; da Costa J
    Br J Haematol; 1974 Jun; 27(2):363-4. PubMed ID: 4367720
    [No Abstract]   [Full Text] [Related]  

  • 3. A new vasopressin analogue and fibrinolysis.
    Gader AM; da Costa J; Cash JD
    Lancet; 1973 Dec; 2(7843):1417-8. PubMed ID: 4128727
    [No Abstract]   [Full Text] [Related]  

  • 4. Probes for vasopressin receptors. Attachment of affinity and fluorescent groups in vasopressin.
    Buku A; Gazis D
    Int J Pept Protein Res; 1990 Feb; 35(2):128-32. PubMed ID: 2157680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Salicylic acid derivatives as fibrinolysis activators].
    Bruhn HD
    Verh Dtsch Ges Inn Med; 1969; 75():490-2. PubMed ID: 5400186
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of diabetes insipidus with 1-desamino-8-D-arginine-vasopressin (author's transl)].
    Irmscher K; Sennejunker K; Wiegelmann W; Solbach HG
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2431-7. PubMed ID: 4614967
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of some synthetic arginyl and lysyl compounds on clotting and fibrinolysis.
    Weinstein MJ; Doolittle RF
    Thromb Diath Haemorrh; 1972 Oct; 28(2):289-97. PubMed ID: 4639661
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of human plasminogen with deoxyribonucleic acids. II. Protection of human plasminogen against catalytic activation with deoxyribonucleic acids.
    Hakim AA
    Enzymologia; 1970 Jan; 38(1):57-81. PubMed ID: 4244649
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative potency of arginine-8-vasopressin and lysine-8-vasopressin in humans.
    Miller L; Fisch L; Kleeman CR
    J Lab Clin Med; 1967 Feb; 69(2):270-91. PubMed ID: 6016625
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antidiuretic and pressor effects of arginine-8-vasopressin, lysine-8-vasopressin, phenylalanine-2-lysine-8-vasopressin in man].
    GUHL U
    Schweiz Med Wochenschr; 1961 Jul; 91():798-804. PubMed ID: 13709554
    [No Abstract]   [Full Text] [Related]  

  • 13. Specificity in the factor VIII response to vasopressin infusion in man.
    Prowse CV; Sas G; Gader AM; Cort JH; Cash JD
    Br J Haematol; 1979 Mar; 41(3):437-47. PubMed ID: 427046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vasopressin and oxytocin].
    Yoshida H
    Horumon To Rinsho; 1973 Nov; 21(11):1113-6. PubMed ID: 4592116
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of action and structural requirements of vasopressin analog inhibition of transepithelial water flux in toad urinary bladder.
    Mann WA; Stassen F; Huffman W; Kinter LB
    J Pharmacol Exp Ther; 1986 Aug; 238(2):401-6. PubMed ID: 3090234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of cholinergic receptors in the reactions of the hemostasis system to vasopressin].
    Kalishevskaia TM; Golubeva MG; Solo'veva ME
    Fiziol Zh (1978); 1989; 35(5):9-14. PubMed ID: 2591588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between the influence of arginine-vasopressin and lysine-vasopressin on water and electrolyte excretion in ewes.
    Kühn E
    Arch Int Pharmacodyn Ther; 1967 Aug; 168(2):417-25. PubMed ID: 6049335
    [No Abstract]   [Full Text] [Related]  

  • 19. The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies.
    van de Kar NC; van Hinsbergh VW; Brommer EJ; Monnens LA
    Pediatr Res; 1994 Aug; 36(2):257-64. PubMed ID: 7970942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of antidiuresis obtained by infusion of arginine-vasopressin (AVP), of lysine-vasopressin (LVP) and oxytocin on calcium excretion in sheep].
    Kühn E
    Arch Int Pharmacodyn Ther; 1966 Apr; 160(2):480-4. PubMed ID: 5954042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.